Dr. Gary Small, M.D.

2 Weeks To a Younger Brain
Misplacing your keys, forgetting someone's name at a party, or coming home from the market without the most important item — these are just some of the many common memory slips we all experience from time to time.


The Memory Bible
The international bestseller that provides pioneering brain-enhancement strategies, memory exercises, a healthy brain diet, and stress reduction tps for enhancing cognitive function and halting memory loss.

Gary Small, M.D., is the Director of Behavioral Health Breakthrough Therapies at Hackensack Meridian Health, New Jersey’s largest, most comprehensive and integrated healthcare network. Dr. Small has often appeared on the TODAY show, Good Morning America, and CNN and is co-author (with his wife Gigi Vorgan) of 10 popular books, including New York Times bestseller, “The Memory Bible,” “The Small Guide to Anxiety,” and “The Small Guide to Alzheimer’s Disease.”

Tags: migraine | headache | fremanezumab | side effects
OPINION

New Migraine Medicine

Dr. Small By Tuesday, 09 January 2018 04:42 PM EST Current | Bio | Archive

Approximately 1 in 10 people experience migraine headaches, and a new study points to hope for these people who suffer from this sometimes debilitating condition.

These severe headaches can last for hours or more and may be accompanied by light or sound sensitivity as well as nausea. 

In a recent study published in the New England Journal of Medicine, investigators looking at the effect of the monoclonal antibody fremanezumab, randomized over 1,000 migraine sufferers into one of three groups that received either an injection of fremanezumab (675 mg the first month and then a placebo at weeks four and eight); monthly treatments of fremanezumab with a starting dose of 675 mg and then 225 mg for the second and third month; or a placebo for all three months. 

More than 43 percent of volunteers taking the lowest dose of the drug fremanezumab and 50 percent of volunteers taking the highest dose experienced approximately half as many migraine headaches.

Side effects from the medication were relatively mild.

© 2026 NewsmaxHealth. All rights reserved.


Dr-Small
Approximately 1 in 10 people experience migraine headaches, and a new study points to hope for these people who suffer from this sometimes debilitating condition.
migraine, headache, fremanezumab, side effects
166
2018-42-09
Tuesday, 09 January 2018 04:42 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved